Tilray (NASDAQ:TLRY) Trading Up 0.8%

Tilray Inc (NASDAQ:TLRY) shares rose 0.8% during mid-day trading on Thursday . The stock traded as high as $2.51 and last traded at $2.50. Approximately 16,859,926 shares traded hands during trading, a decline of 33% from the average daily volume of 25,174,572 shares. The stock had previously closed at $2.48.

Tilray Trading Down 0.4 %

The company’s fifty day moving average price is $1.87 and its 200-day moving average price is $2.00. The stock has a market cap of $1.83 billion, a price-to-earnings ratio of -1.13 and a beta of 2.30. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.63 and a quick ratio of 0.99.

Insider Activity at Tilray

In other news, CEO Irwin D. Simon bought 53,700 shares of the company’s stock in a transaction that occurred on Friday, January 12th. The shares were purchased at an average price of $1.88 per share, for a total transaction of $100,956.00. Following the completion of the transaction, the chief executive officer now directly owns 2,033,058 shares in the company, valued at $3,822,149.04. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CFO Carl A. Merton acquired 20,000 shares of the stock in a transaction on Friday, January 12th. The shares were acquired at an average price of $1.87 per share, for a total transaction of $37,400.00. Following the transaction, the chief financial officer now owns 20,000 shares in the company, valued at approximately $37,400. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, CEO Irwin D. Simon acquired 53,700 shares of the stock in a transaction on Friday, January 12th. The stock was bought at an average price of $1.88 per share, for a total transaction of $100,956.00. Following the transaction, the chief executive officer now owns 2,033,058 shares in the company, valued at approximately $3,822,149.04. The disclosure for this purchase can be found here. Insiders have bought a total of 96,300 shares of company stock worth $183,210 over the last quarter. Insiders own 0.68% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Clear Street Markets LLC acquired a new position in shares of Tilray during the 3rd quarter worth approximately $25,000. Macquarie Group Ltd. raised its stake in shares of Tilray by 188.8% during the 2nd quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock worth $27,000 after buying an additional 5,583 shares during the period. Oppenheimer & Co. Inc. acquired a new position in shares of Tilray during the 4th quarter worth approximately $27,000. Lake Street Financial LLC acquired a new position in shares of Tilray during the 3rd quarter worth approximately $28,000. Finally, Gainplan LLC acquired a new position in shares of Tilray during the 4th quarter worth approximately $28,000. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.